These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3363646)

  • 1. Correlation of blood levels and tissue levels of cyclosporine with the histologic features of cyclosporine toxicity.
    Kumar MS; White AG; Alex G; Antos MS; Philips EM; Abouna GM
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):407-13. PubMed ID: 3363646
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental cyclosporine nephrotoxicity in the rat: effect of biliary ligation and cannulation.
    Heys SD; Duncan JI; Whiting PH
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):845-9. PubMed ID: 3388518
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclosporine: toxicity, metabolism, and drug interactions--implications from animal studies.
    Whiting PH; Thomson AW; Simpson JG
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):134-44. PubMed ID: 3895654
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclosporine A administration: once a day or in fractional doses?
    Dieperink H; Leyssac PP; Starklint H; Kemp E
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):703-6. PubMed ID: 3284118
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclosporine chronic nephrotoxicity: histologic follow-up at 6 and 18 months after renal transplantation.
    Savoldi S; Scolari F; Sandrini S; Scaini P; Sacchi G; Tardanico R; Camerini C; Salerni B; Tonini G; De Nobili U
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):777-84. PubMed ID: 3291313
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma and tissue cyclosporine A concentrations in developing rats.
    Levy-Marchal C; Tarr A; Lokiec F; Czernichow P
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):696-702. PubMed ID: 3363666
    [No Abstract]   [Full Text] [Related]  

  • 7. Predominance of native cyclosporine over metabolites in rat blood and tissue.
    Pell MA; Rosano TG; Brayman KL; Freed BM; Shaw LM; Lempert N
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):674-9. PubMed ID: 3363664
    [No Abstract]   [Full Text] [Related]  

  • 8. Renal dysfunction in animal models of cyclosporine toxicity.
    Paller MS; Murray BM
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):155-9. PubMed ID: 3895656
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolism of cyclosporine.
    Maurer G
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):19-26. PubMed ID: 3895660
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of infusion duration on the efficacy and toxicity of intravenous cyclosporine in bone marrow transplant patients.
    McGuire TR; Tallman MS; Yee GC; Nemunaitis JJ; Higano CS; McGuffin RW; Singer JW
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):501-4. PubMed ID: 3291288
    [No Abstract]   [Full Text] [Related]  

  • 11. Time course of cyclosporine and ist motabolites in blood, liver and spleen of naive Lewis rats: comparison with preliminary data obtained in transplanted animals.
    Wacher VJ; Liu T; Roberts JP; Ascher NL; Benet LZ
    Biopharm Drug Dispos; 1995 May; 16(4):303-12. PubMed ID: 7548779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolites of cyclosporine: blood and tissue levels. Biological activity?
    Humbert H
    Int J Rad Appl Instrum B; 1990; 17(7):723-7. PubMed ID: 2262340
    [No Abstract]   [Full Text] [Related]  

  • 13. Is cyclosporine-associated nephrotoxicity progressive?
    Vanrenterghem Y; Waer M; Roels L; Lerut T; Michielsen P
    Transplant Proc; 1987 Oct; 19(5):4031-2. PubMed ID: 3313992
    [No Abstract]   [Full Text] [Related]  

  • 14. Histopathology of cyclosporine nephrotoxicity.
    Mihatsch MJ; Thiel G; Ryffel B
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):759-71. PubMed ID: 3291311
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclosporine: a double-edged sword.
    Keown PA; Stiller CR
    Hosp Pract (Off Ed); 1987 May; 22(5):207-15, 219-20. PubMed ID: 3106374
    [No Abstract]   [Full Text] [Related]  

  • 16. Morphology of cyclosporine nephrotoxicity in the rat.
    Mihatsch MJ; Ryffel B; Hermle M; Brunner FP; Thiel G
    Clin Nephrol; 1986; 25 Suppl 1():S2-8. PubMed ID: 3708932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late cyclosporine conversion carries risk of irreversible rejection.
    Sagalowsky AI; Reisman ME; Dawidson I; Toto R; Peters PC; Helderman JH
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):157-60. PubMed ID: 3291233
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cyclosporin, toxicity and efficacy in rejection of liver allografts in the rat].
    Settaf A; Gugenheim J; Lahlou MK; Gigou M; Capron-Laudereau M; Charpentier B; Reynes M; Lokiec F; Bismuth H
    J Chir (Paris); 1989; 126(8-9):431-7. PubMed ID: 2808556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects and side effects of cyclosporine: relationship to drug pharmacokinetics.
    Keown PA; Stiller CR; Laupacis AL; Howson W; Coles R; Stawecki M; Koegler J; Carruthers G; McKenzie N; Sinclair NR
    Transplant Proc; 1982 Dec; 14(4):659-61. PubMed ID: 6762722
    [No Abstract]   [Full Text] [Related]  

  • 20. First month cyclosporine A sparing in renal transplantation.
    Segoloni GP; Messina M; Colla L; Piccoli GB; Triolo G; Vercellone A
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):233-8. PubMed ID: 3291249
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.